【24h】

Venous thromboembolism in neonates and children - Update 2013

机译:新生儿和儿童的静脉血栓栓塞症-2013年更新

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Thromboses (VTE) in children were associated with medical diseases with and without acquired or inherited thrombophilic risk factors (IT). Disease recurrence rates vary between 3% in children with a first event during the neonatal period and 21% in children with idiopathic VTE. Recently reported systematic reviews showed significant associations between VTE and factor V G1691A or factor II G20210A mutations, protein C, protein S and antithrombin deficiency, more pronounced when combined IT were involved. The factor II G20210A mutation, protein C, protein S, and antithrombin deficiency did also play an important role at VTE recurrence. Primarily asymptomatic family members of pediatric VTE index cases showed annual VTE incidence rates of 2.82% in carriers of antithrombin, protein C, or protein S deficiency, 0.42% and 0.25% in carriers of the factor II G202010A or V G1691A mutation, and 0.10% in relatives with no IT. ? 2013 Elsevier Ltd. All rights reserved.
机译:儿童血栓形成(VTE)与有或没有获得性或遗传性血栓形成危险因素(IT)的医学疾病有关。疾病复发率在新生儿期初发儿童中为3%,在特发性VTE儿童中为21%。最近报道的系统评价显示,VTE与因子V G1691A或因子II G20210A突变,蛋白C,蛋白S和抗凝血酶缺乏症之间存在显着关联,当涉及联合IT时更为明显。因子II G20210A突变,蛋白C,蛋白S和抗凝血酶缺乏症在VTE复发中也起着重要作用。小儿VTE指数病例的主要无症状家庭成员显示,抗凝血酶,蛋白C或蛋白S缺乏症携带者的年VTE发生率为2.82%,II型G202010A或V G1691A突变携带者的年VTE发生率为0.42%和0.25%,没有IT的亲戚。 ? 2013 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号